Cargando…
D24. Beyond Cost-effectiveness of Treatment for Dupuytren Disease: What is the Financial Impact on Healthcare Providers?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125660/ http://dx.doi.org/10.1097/01.GOX.0000934708.12206.7f |
_version_ | 1785030070530736128 |
---|---|
author | Kuo, Shih-Chiang Edward Ngaage, Ledibabari Mildred Shores, Jaimie T. |
author_facet | Kuo, Shih-Chiang Edward Ngaage, Ledibabari Mildred Shores, Jaimie T. |
author_sort | Kuo, Shih-Chiang Edward |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10125660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101256602023-04-26 D24. Beyond Cost-effectiveness of Treatment for Dupuytren Disease: What is the Financial Impact on Healthcare Providers? Kuo, Shih-Chiang Edward Ngaage, Ledibabari Mildred Shores, Jaimie T. Plast Reconstr Surg Glob Open AAPS 2023 Meeting Abstract Supplement Lippincott Williams & Wilkins 2023-04-26 /pmc/articles/PMC10125660/ http://dx.doi.org/10.1097/01.GOX.0000934708.12206.7f Text en Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | AAPS 2023 Meeting Abstract Supplement Kuo, Shih-Chiang Edward Ngaage, Ledibabari Mildred Shores, Jaimie T. D24. Beyond Cost-effectiveness of Treatment for Dupuytren Disease: What is the Financial Impact on Healthcare Providers? |
title | D24. Beyond Cost-effectiveness of Treatment for Dupuytren Disease: What is the Financial Impact on Healthcare Providers? |
title_full | D24. Beyond Cost-effectiveness of Treatment for Dupuytren Disease: What is the Financial Impact on Healthcare Providers? |
title_fullStr | D24. Beyond Cost-effectiveness of Treatment for Dupuytren Disease: What is the Financial Impact on Healthcare Providers? |
title_full_unstemmed | D24. Beyond Cost-effectiveness of Treatment for Dupuytren Disease: What is the Financial Impact on Healthcare Providers? |
title_short | D24. Beyond Cost-effectiveness of Treatment for Dupuytren Disease: What is the Financial Impact on Healthcare Providers? |
title_sort | d24. beyond cost-effectiveness of treatment for dupuytren disease: what is the financial impact on healthcare providers? |
topic | AAPS 2023 Meeting Abstract Supplement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125660/ http://dx.doi.org/10.1097/01.GOX.0000934708.12206.7f |
work_keys_str_mv | AT kuoshihchiangedward d24beyondcosteffectivenessoftreatmentfordupuytrendiseasewhatisthefinancialimpactonhealthcareproviders AT ngaageledibabarimildred d24beyondcosteffectivenessoftreatmentfordupuytrendiseasewhatisthefinancialimpactonhealthcareproviders AT shoresjaimiet d24beyondcosteffectivenessoftreatmentfordupuytrendiseasewhatisthefinancialimpactonhealthcareproviders |